TRAILR4/TNFRSF10D/DcR2 Antibody

Product Specs
ItemTRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price $429.00Supplier Page View Company Product Page
Catalog NumberNBP1-76985
Conjugate/TagUnconjugated
ImmunogenAntibody was raised against a 15 amino acid peptide near the center of human DcR2. The immunogen is located within amino acids 230 - 280 of DcR2
ReactivityHuman,Mouse,Rat
Concentration1 mg/ml
ClonalityPolyclonal
Molecular Weight36 kDa
IsotypeIgG
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles
Antibody TypePrimary Antibodies
NCBI Gene AliasesTRAILR4, CD264, DCR2, TRUNDD, TRAIL-R4
NCBI Full Gene NameTNF receptor superfamily member 10d
ApplicationsWB, ELISA, FCM, ICC, IF, IHC, IHC-p
Research AreaApoptosis, Cancer, Cell Biology, Cytokine Research, Immunology, Innate Immunity
PurityPeptide affinity purified
HostRabbit
TargetTRAILR4/TNFRSF10D/DcR2
Quantity0.1 mg (also 0.025 mg)
FormatPBS

Specifications/Features

Available conjugates: Available conjugates: Unconjugated

Sizes Available: 0.1 mg (also 0.025 mg)

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritisJournal of gastroenterology and hepatologyJuly 1, 2003Koyama S.

(2) Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivityCancer researchJanuary 1, 0001"Liu X, Yue P, Khuri FR, Sun SY."

(3) Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexesMolecular cancer therapeuticsJanuary 1, 0001"Allen JE, Ferrini R, Dicker DT, Batzer G, Chen E, Oltean DI, Lin B, Renshaw MW, Kretz-Rommel A, El-Deiry WS."

(4) "Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway"The Journal of biological chemistryJanuary 1, 0001"Gupta SC, Francis SK, Nair MS, Mo YY, Aggarwal BB."

(5) Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivoNeuro-oncologyJanuary 1, 0001"Nagane M, Shimizu S, Mori E, Kataoka S, Shiokawa Y."

(6) Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cellsCancer researchJanuary 1, 0001"Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T."

(7) Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathwaysBloodJanuary 1, 0001"Lunghi P, Giuliani N, Mazzera L, Lombardi G, Ricca M, Corradi A, Cantoni AM, Salvatore L, Riccioni R, Costanzo A, et al."

(8) Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cellsThe American journal of pathologyJanuary 1, 0001"Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N."

(9) Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumorJournal of cancer research and clinical oncologyJanuary 1, 0001"Koyama S, Koike N, Adachi S."

(10) Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivoCancer chemotherapy and pharmacologyJanuary 1, 0001"Fan QL, Zou WY, Song LH, Wei W."

(11) Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencingInvestigative ophthalmology & visual scienceJanuary 1, 0001"Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, et al."

(12) Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligandCancer researchJanuary 1, 0001"Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I."

(13) Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surfaceCancer researchJanuary 1, 0001"Kawakubo T, Okamoto K, Iwata J, Shin M, Okamoto Y, Yasukochi A, Nakayama KI, Kadowaki T, Tsukuba T, Yamamoto K."

(14) Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5Cancer researchJanuary 1, 0001"Mitsiades N, Poulaki V, Mitsiades C, Tsokos M."

(15) Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implicationsOncogeneJanuary 1, 0001"Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, et al."

(16) The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoproteinThe Journal of biological chemistryJanuary 1, 0001"Basile JR, Zacny V, Münger K."

(17) TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applicationsBloodJanuary 1, 0001"Mitsiades CS, Treon SP, Mitsiades N, Shima Y, Richardson P, Schlossman R, Hideshima T, Anderson KC."

(18) Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsBloodJanuary 1, 0001"Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP."

(19) Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cellsEndocrine-related cancerJanuary 1, 0001"Zhang HY, Wang HQ, Liu HM, Guan Y, Du ZX."

(20) HIF-1α Mediates TRAIL-Induced Neuronal Apoptosis via Regulating DcR1 Expression Following Traumatic Brain InjuryFrontiers in cellular neuroscienceJanuary 1, 0001"Fang Y, Lu J, Wang X, Wu H, Mei S, Zheng J, Xu S, Lenahan C, Chen S, Zhang J, et al."(1:1,000, Abcam, Waltham, MA, USA, ab133658), anti-DcR2 antibody (1:1,000, Novus, St Charles, MO, USA, NBP1-76985), anti-HIF-1α antibody (1:500, Abcam, Cambridge, MA, USA, ab2185), anti-caspase-3 antibody (1:1,000,

Be the First to Write a Review!

TRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free

TRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free

TRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free

TRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free

TRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free from Novus Biologicals, a Bio-Techne Brand

Specifications/Features

Novus Biologicals, a Bio-Techne Brand

Citations (20)

Reviews

TRAILR4/TNFRSF10D/DcR2 Antibody - BSA Free from Novus Biologicals, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map